Please select the option that best describes you:

With the current cisplatin and carboplatin shortages, for HPV+ H&N patients with indications for concurrent chemoRT, which agent do you recommend next?   

If using cetuximab, would you recommend accelerated fractionation?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at University of Michigan
Agree with Dr. @Garden regarding taxanes as an alt...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice